Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting up to six million people in the United States and more than 35 million individuals worldwide. Thromboembolism, including stroke, represents the most common AF-related morbidity and mortality and data indicate that an...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Jason D., Waks, Jonathan W., Zimetbaum, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2018
Materias:
Research Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252665/
https://www.ncbi.nlm.nih.gov/pubmed/32477807
http://dx.doi.org/10.19102/icrm.2018.090404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252665/
https://www.ncbi.nlm.nih.gov/pubmed/32477807
http://dx.doi.org/10.19102/icrm.2018.090404

Ejemplares similares